Organizations Call On Congress to Encourage Prescription Competition

A large group of organizations are calling on Congress to remove regulatory barriers in order to allow generic drug makers to have access to brand name drugs for FDA testing and approval.  The bill would encourage competitive entry once brand name drug patents have expired, permitting new rivals to provide lower cost drugs to doctors […]